Skip to main content
. Author manuscript; available in PMC: 2023 Nov 1.
Published in final edited form as: Can J Cardiol. 2022 Aug 4;38(11):1742–1750. doi: 10.1016/j.cjca.2022.07.018

Table 2:

MELD-XI Score and Hepatorenal Dysfunction

MELD-XI HRD (MELD-XI ≥11) Mild/mod HRD (MELD-XI 11–15) Severe HRD (MELD-XI >15)

All patients 9.5 (9.4–12.6) 1,376 (28%) 935 (19%) 441 (9%)
Congenital heart lesions
Coarctation of aorta 9.4 (9.4–11.2) 209 (26%) 175 (22%) 34 (4%)
Tetralogy of Fallot 10.9 (9.8–13.6) 253 (34%) 180 (24%) 73 (10%)
Ebstein anomaly 10.6 (9.5–12.8) 212 (31%) 151 (22%) 61 (9%)
Congenital aortic stenosis (isolated) 9.4 (9.4–10.9) 125 (19%) 82 (12%) 43 (7%)
Fontan palliation 11.2 (10.1–14.6) 169 (46%) 100 (27%) 69 (19%)
Atrioventricular canal defect 9.5 (9.4–11.3) 85 (28%) 54 (18%) 31 (10%)
ASD/PAPVR (repaired) 9.4 (9.4–10.7) 67 (24%) 46 (17%) 21 (7%)
Valvular pulmonic stenosis 9.4 (9.4–10.3) 41 (17%) 23 (10%) 18 (8%)
Congenitally corrected TGA 9.6 (9.4–12.6) 47 (23%) 28 (14%) 19 (9%)
TGA status post atrial switch operation 9.4 (9.4–11.2) 34 (17%) 18 (10%) 16 (9%)
TGA status post arterial switch operation 9.4 (9.4–9.9) 30 (18%) 17 (10%) 13 (8%)
Subaortic stenosis (isolated) 9.4 (9.4–10.5) 25 (19%) 16 (12%) 9 (7%)
Eisenmenger /unrepaired single ventricle 11.4 (10.9–13.7) 37 (49%) 21 (28%) 16 (21%)
Pulmonary atresia-intact ventricular septum 11.1 (10.4–14.3) 21 (48%) 11 (25%) 10 (23%)
Truncus arteriosus 9.9 (9.5–12.8) 10 (26%) 5 (14%) 5 (13%)
Double chambered RV 9.4 (9.4–10.6) 6 (19%) 4 (13%) 2 (6%)
ASD/APVR (unrepaired) 9.5 (9.4–10.8) 5 (21%) 4 (17%) 1 (4%)

TGA: Transposition of great arteries; ASD/PAPVR: atrial septal defect/partial anomalous pulmonary venous return; MELD-XI: model for end-stage liver disease excluding international normalized ratio; HRD: hepatorenal dysfunction

Note: (%) denotes the prevalence of hepatorenal dysfunction within each congenital heart lesion